MORGAN STANLEY

Position in GUTS — Fractyl Health, Inc.

CIK 895421 NEW YORK, NY

Position in GUTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$227,122

-$1,217,136 QoQ

Shares Held

495,901

-24.5% QoQ

Ownership

0.313%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. GUTS ranks #324 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$227,122	495,901	-24.5%	Shares	Defined	2026-05-15
2025-12-31	$1,444,258	656,482	+52.6%	Shares	Defined	2026-05-27
2025-09-30	$684,066	430,231	+174.2%	Shares	Defined	2026-05-27
2025-06-30	$254,160	156,890	-2.0%	Shares	Defined	2025-08-15
2025-03-31	$190,443	160,039	-40.9%	Shares	Defined	2025-05-15
2024-12-31	$557,897	270,825	+61.9%	Shares	Defined	2025-05-15
2024-09-30	$423,207	167,276	+129.3%	Shares	Defined	2025-05-14
2024-06-30	$311,555	72,964	-73.8%	Shares	Defined	2025-05-14
2024-03-31	$2,061,195	278,540	—	Shares	Defined	2024-10-17
No filing history on record for this holder in this stock.